Joel E. Gallant, MD, MPH, and Charles B. Hicks, MD, review timing and choice of first-line antiretroviral therapy in this unique program with a didactic video module and several case-based vignettes in which you are invited to help manage the patient.
Upon completion of this activity, participants should be able to:
Sizing Up the Newest Integrase Inhibitor–Based Single-Tablet Regimen
Evolving Switch Strategies for Virologically Suppressed HIV-Infected Patients
To Switch or Not to Switch: Management of First-line Boosted PI Virologic Failure
Choosing a Single-Tablet Regimen for HIV Patients: What Do the Latest IAS-USA Guidelines Have to Say?
What 5257 Tells Us About the Selection of Integrase Inhibitor Regimens For HIV Therapy
Clinical Care Options, LLC. All Rights Reserved.